---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-082637"
form_type: "8-K"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2024-07-25T23:59:59+00:00"
generated_at: "2026-05-31T16:34:52.884502+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Armata formalizes CMO Pastagia's salary at $456,800; improves severance to 12 months

## Summary
- Dr. Pastagia's base salary confirmed at $456,800 (effective Jan 1, 2023).
- Target bonus increased to 50% of salary for FY2024; no 2023 bonus awarded.
- Eligible for annual equity grants starting 2025; current intent ~$300,000 fair value.
- Severance extended from 6 to 12 months base salary for involuntary termination without cause.
- Amendment also updates title to Chief Medical Officer (serving since Jan 1, 2023).

## SEC filing metadata
- accession: 0001104659-24-082637
- form_type: 8-K
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2024-07-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/0001104659-24-082637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465924082637/tm2420145d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-082637
- JSON: https://secwatch.observer/filing/0001104659-24-082637.json
- Plain text: https://secwatch.observer/filing/0001104659-24-082637.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.